Low-Dose CT Scan for Lung Cancer Screening: Clinical and Coding Considerations

Area of Science:

• Pulmonology
• Radiology
• Preventive Medicine

Background:

• The National Lung Screening Trial demonstrated low-dose CT (LDCT) scan effectiveness in reducing lung cancer mortality.
• Centers for Medicare and Medicaid Services (CMS) coverage of LDCT scans is established, despite real-world effectiveness uncertainties.

Purpose of the Study:

• To review evidence supporting lung cancer screening with LDCT scans.
• To outline practical aspects of the required counseling and shared decision-making visit.
• To discuss billing considerations and implications of the CMS National Coverage Determination.

Main Methods:

• Review of existing literature on lung cancer screening and LDCT efficacy.
• Analysis of CMS National Coverage Determination requirements for LDCT reimbursement.
• Examination of counseling protocols, shared decision-making, and smoking cessation integration.

Main Results:

• CMS mandates a pre-screening counseling and shared decision-making visit for LDCT coverage.
• Patient eligibility, screening adherence, and smoking cessation are key discussion points during the visit.
• New billing codes are available for the counseling visit and the LDCT scan itself.

Conclusions:

• CMS coverage of LDCT screening represents a significant step in preventive lung cancer care.
• Effective implementation requires adherence to counseling guidelines and shared decision-making principles.
• The CMS decision has broader implications for quality assurance in screening test implementation.